🔎 Trials Near Me

Akèy › Dematomiyozit › Texas

Etid klinik pou Dematomiyozit nan Texas

6 etid pou Dematomiyozit ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • ak 2 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
  • Houston Methodist Hospital - Accepting Adult Patients, Houston
  • University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
Ap rekriteFaz 2/3
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  • Integrative Rheumatology of South Texas, Edinburg
  • Arthritis & Rheumatology Research Institute, PLLC, Frisco
  • Integrative Rheumatology of South Texas, Harlingen
  • ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05895786

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • Arthritis & Rheumatology Research Institute, PLLC, Frisco
  • Nerve & Muscle Center of Texas, Houston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06698796

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • Austin Neuromuscular Center, Austin
  • Nerve and Muscle Center of Texas, Houston
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jul 22, 2026 · NCT06371417

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.